Delivery Order SPE2DB24D3013-SPE2DB25FFLQY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a contract ceiling value of $1,253.32. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 2, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $7,460.48. This firm fixed price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $2,015.92. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Ozempic (0.25-0.5 mg/dose) pens in 3ml quantities, valued at $5,043.18. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, representing a non-competitive set-aside award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $69,836.34 on June 2, 2025, for Ozempic 0.25–0.5 mg/dose pens (3 mL). This firm fixed-price contract, with an ultimate completion date of June 3, 2025, was issued on a non-set-aside basis and represents a competitively awarded transaction. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is executed under a...
- The Defense Logistics Agency awarded a $9,656.92 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ozempic (0.25-0.5 mg/dose) pens in 3 ml quantities. The contract represents a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml vials, with a contract ceiling value of $4,527.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order...
- The Defense Logistics Agency awarded a $3,244.42 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $5,513.90 delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3 mL vials, with a completion date of June 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This...
- The Defense Logistics Agency awarded a $25,129.53 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract utilized no set-aside designations and specifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is structured as a child contract under a larger vehicle, leveraging...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFLQYDelivery Order
The Defense Logistics Agency awarded a $3,949.57 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed price contract type. The order is set to be completed by May 13, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania location. This delivery order is a non-set-aside award made through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive vehicle for supplying pharmaceuticals and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, and other critical medical commodities across multiple therapeutic domains. The Ozempic delivery order represents a routine fulfillment of diabetes medication needs for Defense Health Agency and other federal healthcare systems supported through this strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 5/12/25 |